Stereotaxis, Inc. (STXS) Financials
STXS Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 44.5 million | 20.2 million |
2023-06-30 | 48.3 million | 21.3 million |
2023-03-31 | 50.7 million | 21.4 million |
2022-12-31 | 53.4 million | 21.5 million |
STXS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -977000 | 2.7 million |
2023-06-30 | -2.9 million | 2.7 million |
2023-03-31 | -3.2 million | 2.7 million |
2022-12-31 | -2.9 million | 2.7 million |
STXS Net Income
No data available :(
STXS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 22.1 million | - | 5.6 million |
2023-06-30 | 22.9 million | - | 5.7 million |
2023-03-31 | 25.7 million | - | 5.8 million |
2022-12-31 | 28.4 million | - | 5.9 million |
STXS Shares Outstanding
STXS Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 10000 | 2.7 million | 3.9 million | 3.1 million |
2023-06-30 | 7000 | 2.6 million | 3.5 million | 3.3 million |
2023-03-31 | 349000 | 2.7 million | 3.6 million | 3.1 million |
2022-12-31 | 369000 | 2.4 million | 3.4 million | 3.0 million |
STXS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 7.8 million | 3.7 million |
2023-06-30 | 7.9 million | 3.7 million |
2023-03-31 | 6.5 million | 2.7 million |
2022-12-31 | 7.3 million | 3.0 million |
STXS
Price: $2.30
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.27 USD
P/E Ratio: -8.04
Exchange: ASE
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 50343
Ebitda: -5.0 millionMarket Capitalization: 239.0 million